Medivir AB (publ) (STO:MVIR)
1.498
-0.008 (-0.53%)
Oct 13, 2026, 11:29 AM CET
Medivir AB Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Medivir AB stock has an average price target of kr 4.93. The average 1-year stock price forecast is 229.11% higher than the current stock price, while the lowest is kr 4.10 (+173.70%) and the highest is kr 6.94 (+363.28%).
Price Target: kr 4.93 (+229.11%)
Analyst Consensus: n/a
Price Target
ChartAnalyst Ratings
According to 1 stock analyst, the rating for Medivir AB is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jun '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Financial Forecast
Revenue This Year
4.30M
from 8.51M
Decreased by -49.45%
Revenue Next Year
148.50M
from 4.30M
Increased by 3,353.48%
EPS This Year
-0.13
EPS Next Year
-0.15
from -0.13
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.